Health and Healthcare
FDA Warns Consumers to Discard Dr. Berne and LightEyez Eye Drops
Published:
The U.S. Food and Drug Administration (FDA) has issued a notice warning consumers not to purchase or use existing supplies of Dr. Berne’s MSM Eye Drops 5% Solution and LightEyez MSM Eye Drops due to “bacterial contamination, fungal contamination, or both.” (These are history’s worst medical scandals.)
[in-text-ad]
Recent testing of the eye drops showed that the products were “contaminated with microbes and were not sterile.” The FDA requires that eye drops be sterile in order to be safely used. The agency further recommends that consumers discard these products.
One of the active ingredients in both brands, methylsulfonylmethane (MSM), is an unapproved drug and is being illegally marketed in the United States. There are no legally marketed drugs containing MSM available in this country.
On Monday, the manufacturer of the drops, Dr. Berne, verbally agreed to a voluntary recall of Dr. Berne’s MSM Drops 5% Solution. The FDA also sent an email to LightEyez Ltd., maker of LightEyez MSM Eye Drops, asking to discuss the company’s product. LightEyez has not responded.
For more information, see the FDA warning.
100 Million Americans Are Missing This Crucial Retirement Tool
The thought of burdening your family with a financial disaster is most Americans’ nightmare. However, recent studies show that over 100 million Americans still don’t have proper life insurance in the event they pass away.
Life insurance can bring peace of mind – ensuring your loved ones are safeguarded against unforeseen expenses and debts. With premiums often lower than expected and a variety of plans tailored to different life stages and health conditions, securing a policy is more accessible than ever.
A quick, no-obligation quote can provide valuable insight into what’s available and what might best suit your family’s needs. Life insurance is a simple step you can take today to help secure peace of mind for your loved ones tomorrow.
Click here to learn how to get a quote in just a few minutes.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
